Here, we report that in prostate cancer cells, differential binding of AR and HOXB13 on account of varying MYC levels centers on genes regulated by KMT2A/MLL1, which in turn is inversely proportional to the expression of PLA2G4F in cohorts of advanced, but not localized, PCa. The gene discussed is AR; the disease is prostate carcinoma.